Physicians
Overview
Cellvizio system
Education
Reimbursement
GastroEnterology
Barrett’s Esophagus
Pancreatic Cysts
Gastric Disease
Inflammatory Bowel Diseases
Irritable Bowel Syndrome
Bilio-Pancreatic Strictures
Colorectal Lesions
Pulmonology
Lung Nodules
Covid-19
Urology
Investors
About us
Our story
Team
Board of Directors
Leadership
Join Us
Press Coverage
Commercial Network
News & events
US
INT
FR
US
INT
FR
Contact
Search
Search
-
-
Jan 27, 2026
You might also like to read
NEWS - Cellvizio
Jan 25, 2024
Mauna Kea Technologies Reports Full Year 2023 Sales of €10.5m, Up +42% vs 2022
Discover
NEWS - Cellvizio
Nov 13, 2023
Mauna Kea Technologies and Telix Pharmaceuticals to Expand Partnership in Uro-oncologic Surgery
Discover
NEWS - Cellvizio
Jul 11, 2022
Tasly Pharmaceuticals and Mauna Kea Technologies Announce Joint Venture and Licensing Agreements
Discover
